Anthracycline cardiotoxicity in long-term survivors of childhood cancer

By Scully Rebecca   Lipshultz Steven  

Cardiovascular Toxicology, Vol. 7, Iss. 2, 2007-06 ,pp. : 122-128

Humana Press, Inc

Access to resources Recommend Favorite

Novel antioxidants in anthracycline cardiotoxicity

By Hideg Kálmán   Kálai Tamás  

Cardiovascular Toxicology, Vol. 7, Iss. 2, 2007-06 ,pp. : 160-164

Humana Press, Inc

Access to resources Recommend Favorite

Anthracycline-Induced Cardiotoxicity

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 6, Iss. 4, 2008-10 ,pp. : 278-281

Bentham Science Publishers

Access to resources Recommend Favorite

Combined treatment with biphosphonates, low-dose chemotherapy, and trastuzumab in receptor-negative breast cancer patients with bone marrow involvement

By Bezares S.   Amador M.L.   Castellano D.   Trigo J.M.   Cortes-Funes H.   Colomer R.  

European Journal of Internal Medicine, Vol. 12, Iss. 5, 2001-09 ,pp. : 462-463

Elsevier

Access to resources Recommend Favorite

Genotyping the risk of anthracycline-induced cardiotoxicity

By Deng Shiwei   Wojnowski Leszek  

Cardiovascular Toxicology, Vol. 7, Iss. 2, 2007-06 ,pp. : 129-134

Humana Press, Inc

Access to resources Recommend Favorite